Literature DB >> 33300464

Blood norepinephrine/epinephrine/dopamine measurements in 108 patients with takotsubo syndrome from the world literature: pathophysiological implications.

John E Madias1,2.   

Abstract

OBJECTIVES: Release of norepinephrine (NE) from neuronal cardiac nerve endings and/or blood-borne catecholamines (CATs), mainly epinephrine (EPI), may mediate TTS. The aim of this study was to document the levels of NE, EPI, and dopamine (DA) in patients with TTS.
MATERIALS AND METHODS: A qualitative/quantitative meta-analysis of CATs and their relationship to age, gender, and triggers, was carried out, employing the world literature on TTS, published in PubMed.
RESULTS: NE/EPI/DA in108 patients with TTS, 65.2 ± 16.4 years old, 89 (82.4%) women, revealed that: NE was measured more frequently than EPI, and EPI than DA; the timing of the measurements was variable; CATs were reported variably (qualitatively/quantitatively/with/without upper limits of normal); NE/EPI or NE/EPI/DA rose to the same degree; CATs were normal, or mildly/moderately elevated, with only 6 patients showing markedly elevated NE/EP/DA; NE, EPI, and DA were similar in patients with physical triggers and NE was similar in patients with physical, emotional, or no triggers (p = 0.47); EPI was higher than NE in patients with emotional triggers and EPI was higher in patients with emotional than physical triggers (p = 0.012); NE, EPI, and DA rose to the same proportion in men and women; types of TTS triggers were distributed proportionally in men and women.
CONCLUSION: NE, EPI, and DA rise proportionally in patients with TTS; CATs are mildly/moderately, and rarely markedly elevated; measurements of CATs should become more systematised; although CATs may not be essential for TTS diagnosis, they may contribute to prognosis and elucidation of the pathophysiology of TTS.

Entities:  

Keywords:  Takotsubo syndrome; and dopamine and takotsubo syndrome; blood catecholamines and takotsubo syndrome; blood norepinephrine; epinephrine; pathophysiology of takotsubo syndrome

Mesh:

Substances:

Year:  2020        PMID: 33300464     DOI: 10.1080/00015385.2020.1826703

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  5 in total

Review 1.  Insulin and takotsubo syndrome: plausible pathophysiologic, diagnostic, prognostic, and therapeutic roles.

Authors:  John E Madias
Journal:  Acta Diabetol       Date:  2021-04-02       Impact factor: 4.280

2.  Inquiries Arising From a Proposed Coronary Vasospasm-Induced Pathophysiologic Mechanism of Takotsubo Syndrome.

Authors:  John E Madias
Journal:  Tex Heart Inst J       Date:  2022-05-01

3.  Implantation/explantation of sEEG electrodes and takotsubo syndrome: Plausible merits of some additions to the protocol.

Authors:  John E Madias
Journal:  Epilepsia Open       Date:  2021-05-04

Review 4.  Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis.

Authors:  Elias Rawish; Thomas Stiermaier; Francesco Santoro; Natale D Brunetti; Ingo Eitel
Journal:  J Clin Med       Date:  2021-01-28       Impact factor: 4.241

5.  Dopamine D1/D5 Receptor Signaling Is Involved in Arrhythmogenesis in the Setting of Takotsubo Cardiomyopathy.

Authors:  Mengying Huang; Zhen Yang; Yingrui Li; Huan Lan; Lukas Cyganek; Goekhan Yuecel; Siegfried Lang; Karen Bieback; Ibrahim El-Battrawy; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Front Cardiovasc Med       Date:  2022-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.